[1] BEER MF,FRANK FM,GERMÁN ELSOO,et al. Trypanocidal and leishmanicidalactivities of flavonoids isolated from Stevia satureiifolia var. Satureiifolia[J]. Pharm Biol,2016,54(10):2188-2195. [2] COELHO PL,OLIVEIRA M N,DA SILVA AB,et al. The flavonoid apigenin from Croton betulaster Mull inhibits proliferation,induces differentiation and regulates the inflammatory profile of glioma cells[J]. Anticancer Drugs,2016,27(10):960-969. [3] SHALINI V,BHASKAR S,KUMAR K S,et al.Molecular mechanisms of anti-inflammatory action of the flavonoid,tricin from Njavara rice (Oryza sativa L.) in human peripheral blood mononuclear cells:possible role in the inflammatory signaling[J]. Int Immunopharmacol,2012,14(1):32-38. [4] 师继超,赵东双,刘圆圆,等.不同制备工艺所得毛樱桃总黄酮的抗炎活性研究[J].北华大学学报:自然科学版,2017,18(3):345-347. [5] 张成义,邵世和,史玉玲.长白山毛樱桃总黄酮对冻伤及炎症相关性的影响[J].中国免疫学杂志,2010,26(11):977-981. [6] ALLAWI A A D.Malnutrition,inflamation and atherosclerosis (MIA syndrome) in patients with end stage renal disease on maintenance hemodialysis (a single centre experience)[J]. Diabetes Metab Syndr,2018,12(2):91-97. [7] 王晓菲,秦再生.厄洛替尼对脂多糖诱导的巨噬细胞炎症反应和小鼠急性肺损伤的影响[J].吉林大学学报:医学版,2016,42(3):457-461. [8] BRAZIL J C,PARKOS C A.Pathobiology of neutrophil-epithelial interactions[J]. Immunol Rev,2016,273(1):94-111. [9] BRAZIL J C,LOUIS N A,PARKOS C A. The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease[J]. Inflamm Bowel Dis,2013,19(7):1556-1565. [10] 池明,高玲,吴巍巍,等.黄连素对脂多糖诱导的小鼠急性肺损伤和炎症的改善用及其机制[J].吉林大学学报:医学版,2018,44(6):1194-1199. [11] YANG H,WANG H,CZURA C J. The cytokine activity of HMGB1[J]. Leukoc Biol,2005,78(1):1-8. [12] PAPA S,ZAZZERONI F,PHAM C G,et al. Linking JNK signaling to NF-kappaB:a key to surviva[J]. Cell Sci,2004,117(1):5197-5208. [13] CONNELL M J,WALWORTH N C,CARR A M. The G2-phase DNA-damage checkpoint[J]. Trends Cell Biol,2000,10(1):296-303. [14] 苏日古嘎,孟峻.细胞分裂周期蛋白Cdc14A功能的研究进展[J].吉林大学学报:医学版,2018,44(5):1105-1108. [15] BONIZZI G,KARIN M. The two NF-kappa B activation pathways and their role in innate and adaptive immunity[J]. Trends Immunol,2004,25(6):280-288. [16] HOSH S,HAYDEN M S. New regulators of NF-kappa B in inflammation[J]. Nat Rev Immunol,2008,8(11):837-848. [17] MELOCHE S,POUYSSÉGUR J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1-to S-phase transition[J]. Oncogene,2007,26(22):3227-3239. [18] DHILON A S,HAGAN S,RATH O,et al.MAP kinase signalling pathway in a cancer[J]. Oncogene,2007,27(22):3279-3290. [19] SAKURUI T,MACDA S,CHANG L,et al.Loss of hepatic NF-kappa B activity enhaneces chemical hepalocarcinogenesis through suslained c-Jun N-terminal kinase 1 activation[J]. Proc Natl Acad Sci U S A,2006,103(28):10544-10551. [20] KUNTZEN C,SONUC N,DE TONI E N,et al. Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cells ceyle arrest[J]. Cancer Res,2005,65(15):6780-6788. |